Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" [J Virus Erad 9 (2) (June 2023) 100331]
- PMID: 37560051
- PMCID: PMC10407945
- DOI: 10.1016/j.jve.2023.100340
Corrigendum to "HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption" [J Virus Erad 9 (2) (June 2023) 100331]
Abstract
[This corrects the article DOI: 10.1016/j.jve.2023.100331.].
© 2023 The Author(s).
Erratum for
-
HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption.J Virus Erad. 2023 Jun 17;9(2):100331. doi: 10.1016/j.jve.2023.100331. eCollection 2023 Jun. J Virus Erad. 2023. PMID: 37416088 Free PMC article.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources